Pharmacy Question for the Week of October 23, 2017

Pharmacy Compliance Question of the Week


We are hearing a lot lately about something known as DIR. Does this apply to Medicare?


Under Medicare Part D, the Centers for Medicare & Medicaid Services (CMS) make partially capitated payments to private insurers, also known as Part D sponsors, for delivering prescription drug benefits to Medicare beneficiaries. Medicare relies on transaction data reported by Part D sponsors to make sure these payments are accurate. Often, the Part D sponsor or its pharmacy benefits manager (PBM) receives additional compensation after the point-of-sale that serves to change the final cost of the drug for the payer, or the price paid to the pharmacy for the drug. Examples of such compensation include rebates provided by manufacturers and concessions paid by pharmacies. Under Medicare Part D, this post point-of-sale compensation is called direct and indirect remuneration (DIR) and is factored into CMS’s calculation of final Medicare payments to Part D plans.

CMS explains DIR in detail at

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.